Cardiac MR imaging

Radiologic Clinics of North America

Volumn 41, Issue 1, 2003, Pages 17-28

  Castillo, Ernesto ^a   Bluemke, David A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; FUNCTIONAL ANATOMY; HEART DISEASE; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; THREE DIMENSIONAL IMAGING;

CARDIOTONIC AGENTS; CONTRAST MEDIA; DOBUTAMINE; EXERCISE TEST; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 0037284565     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(02)00069-6     Document Type: Review

References (94)

1. Brenner LD, Caputo GR, Mostbeck G, et al. Quantification of left to right atrial shunts with velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 1992;20:1246.
2. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848.
3. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31:1040.
4. Sechtem U, Voth E, Baer F, et al. Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques. Int J Cardiovasc Imaging 1993;9(Suppl 1):31-40.
5. Devlin AM, Moore NR, Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 1999;72:258.
6. Baer FM, Voth E, Schneider CA, et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995;91:1006.
7. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763.
8. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992;70:34.
9. van Rugge FP, van der Wall EE, de Roos A, et al. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol 1993;22:431.
10. van Rugge FP, van der Wall EE, Spanjersberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90:127.
11. Geskin G, Kramer CM, Rogers WJ, et al. Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98:217.
12. Gotte MJ, van Rossum AC, Twisk JWR, et al. Quantification of regional contractile function after infarction: strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium. J Am Coll Cardiol 2001;37(3):808-17.
13. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902.
14. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992.
15. Lima JA, Judd RM, Bazille A, et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995;92:1117.
16. Kim RJ, Chen EL, Lima JA, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94:3318.
17. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000; 101(23):2734-41.
18. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765.
19. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218(1):215-23.
20. Fieno DS, Kim RJ, Chen EL, et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36(6):1985-91.
21. Oshinski JN, Yang Z, Jones JR, et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104(23):2838-42.
22. Saeed M, Bremerich J, Wendland MF, et al. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999;213:247.
23. Schaefer S, Malloy CR, Katz J, et al. Gadolinium- DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol 1988;12:1064.
24. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357(9249):21-8.
25. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2):224-9.
26. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts longterm improvement in contractile function. Circulation 2001;104(10):1101-7.
27. Kim RJ, Wu E, Rafael A, et al. The use of contrast- enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-53.
28. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105(2):162-7.
29. Bottomley PA, Weiss RG. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology 2001; 219(2)
30. Wielopolski PA, van Geuns RJ, de Feyter PJ, et al. Coronary arteries. Eur Radiol 2000;10(1):12-35.
31. Botnar RM, Stuber M, Danias PG, et al. Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional MRA coronary. Circulation 1999;99:3139.
32. Edelman RR, Manning WJ, Burstein D, et al. Coronary arteries: breath-hold MR angiography. Radiology 1991;181:641.
33. Li D, Paschal CB, Haacke EM, et al. Coronary arteries: three-dimensional MR imaging with fat saturation and magnetization transfer contrast. Radiology 1993; 187:401.
34. Hofman MB, Henson RE, Kovacs SJ, et al. Blood pool agent strongly improves 3D magnetic resonance coronary angiography using an inversion pre-pulse. Magn Reson Med 1999;41:360.
35. Li D, Dolan RP, Walovitch RC, et al. Three-dimensional MRI of coronary arteries using an intravascular contrast agent. Magn Reson Med 1998;39:1014.
36. Stuber M, Botnar RM, Kissinger KV, et al. Free-breathing black-blood coronary MR angiography: initial results. Radiology 2001;219(1):278-83.
37. Stuber M, Botnar RM, Danias PG, et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 1999;10:790.
38. Engel HJ, Torres C, Page HLJ. Major variations in anatomical origin of the coronary arteries: anglographic observations in 4,250 patients without associated congenital heart disease. Catheter Cardiovasc Diagn 1975;1:157.
39. Kragel AH, Roberts WC. Anomalous origin of either the right or left main coronary artery from the aorta with subsequent coursing between aorta and pulmonary trunk: analysis of 32 necropsy cases. Am J Cardiol 1988;62:771.
40. McConnell MV, Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995;92:3158.
41. Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 1995;92:3163.
42. Taylor AM, Thorne SA, Rubens MB, et al. Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation 2000;101(14): 1670-8.
43. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation 2002;105(8): 908-11.
44. Vrachliotis TG, Bis KG, Aliabadi D, et al. Contrast-enhanced breath-hold MR angiography for evaluating patency of coronary artery bypass grafts. AJR Am J Roentgenol 1997;168:1073.
45. Wintersperger BJ, Engelmann MG, von Smekal A, et al. Patency of coronary bypass grafts: assessment with breath-hold contrast-enhanced MR angiography - value of a non-electrocardiographically triggered technique. Radiology 1998;208:345.
46. Sakuma H, Globits S, O'Sullivan M, et al. Breath-hold MR measurements of blood flow velocity in internal mammary arteries and coronary artery bypass grafts. J Magn Reson Imaging 1996;6:219.
47. Langerak SE, Kunz P, Vliegen HW, et al. Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress. Radiology 2001; 218(2):540-7.
48. Fernandez-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562.
49. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657.
50. Toussaint JF, Southern JF, Fuster V, et al. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1533.
51. Toussaint JF, LaMuraglia GM, Southern JF, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932.
52. Worthley SG, Helft G, Fuster V, et al. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation 2000;101(25):2956-61.
53. Botnar RM, Stuber M, Kissinger KV, et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000;102(21):2582-7.
54. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102(5):506-10.
55. Botnar RM, Kim WY, Bornert P, et al. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 2001;46(5):848-54.
56. Arai AE, Epstein FH, Bove KE, et al. Visualization of aortic valve leaflets using black blood MRI. J Magn Reson Imaging 1999;10:771.
57. de Roos A, Reichek N, Axel L, et al. Cine MR imaging in aortic stenosis. J Comput Assist Tomogr 1989; 13:421.
58. Globits S, Frank H, Mayr H, et al. Quantitative assessment of aortic regurgitation by magnetic resonance imaging. Eur Heart J 1992;13:78.
59. Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation 1995;92:1151.
60. Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation 1993;87:1239.
61. Yoshida K, Yoshikawa J, Hozumi T, et al. Assessment of aortic regurgitation by the acceleration flow signal void proximal to the leaking orifice in cine-magnetic resonance imaging. Circulation 1991; 83:1951.
62. Bryant DJ, Payne JA, Firmin DN, et al. Measurement of flow with NMR imaging using a gradient pulse and phase difference technique. J Comput Assist Tomogr 1984;8:588.
63. Suzuki J, Caputo GR, Kondo C, et al. Cine MR imaging of valvular heart disease: display and imaging parameters affect the size of the signal void caused by valvular regurgitation. AJR Am J Roentgenol 1990; 155:723.
64. Fontaine G, Fontaliran F, Hebert JL, et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999;50:17-35.
65. Blake LM, Scheinman MM, Higgins CB. MR features of arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol 1994;162:809.
66. Burke AP, Farb A, Tashko G, et al. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 1998;97:1571.
67. Shirani J, Berezowski K, Roberts WC. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995;76:414.
68. Ricci C, Longo R, Pagnan L, et al. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992;70:1589.
69. Suzuki J, Shimamoto R, Nishikawa J, et al. Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging. J Am Coll Cardiol 1999;33:146.
70. Pons-Llado G, Carreras F, Borras X, et al. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 1997;79:1651.
71. Pattynama PM, Lamb HJ, Van DV, et al. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology 1993;187:261.
72. Schulz-Menger J, Strohm O, Waigand J, et al. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 2000;101(15):1764-6.
73. Dong SJ, MacGregor JH, Crawley AP, et al. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study. Circulation 1994;90:1200.
74. Kramer CM, Reichek N, Ferrari VA, et al. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 1994;90:186.
75. Maier SE, Fischer SE, McKinnon GC, et al. Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging. Circulation 1992;86:1919.
76. Kawada N, Sakuma H, Yamakado T, et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999;211:129.
77. Doherty NE, Seelos KC, Suzuki J, et al. Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J Am Coll Cardiol 1992;19:1294.
78. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802.
79. Sechtem U, Higgins CB, Sommerhoff BA, et al. Magnetic resonance imaging of restrictive cardiomyopathy. Am J Cardiol 1987;59:480.
80. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992;182:369.
81. Soulen RL. Magnetic resonance imaging of great vessel, myocardial, and pericardial disease. Circulation 1991;84:I311.
82. Blankenberg F, Eisenberg S, Scheinman MN, et al. Use of cine gradient echo (GRE) MR in the imaging of cardiac hemochromatosis. J Comput Assist Tomogr 1994;18:136.
83. Sechtem U, Pflugfelder PW, Cassidy MM, et al. Mitral or aortic regurgitation: quantification of regurgitant volumes with cine MR imaging. Radiology 1988; 167:425.
84. Watanabe A, Hara Y, Hamada M, et al. A case of effusive-constructive pericarditis: an efficacy of GD-DTPA enhanced magnetic resonance imaging to detect a pericardial thickening. Magn Reson Imaging 1998; 16:347.
85. Burke A, Virmani R. Tumours of the heart and great vessels. In: Atlas of tumor pathology, fasc 16, ser 3. Washington (DC): Armed Forces Institute of Pathology; 1996.
86. Araoz PA, Eklund HE, Welch TJ, et al. CT and MR imaging of primary cardiac malignancies. Radiographics 1999;19:1421.
87. Boxt LM. MR imaging of congenital heart disease. Magn Reson Imaging Clin N Am 1996;4:327.
88. Ho VB, Kinney JB, Sahn DJ. Contributions of newer MR imaging strategies for congenital heart disease. Radiographics 1996;16:43.
89. Fogel MA, Hubbard A, Weinberg PM. A simplified approach for assessment of intracardiac baffles and extracardiac conduits in congenital heart surgery with two- and three-dimensional magnetic resonance imaging. Am Heart J 2001;142(6):1028-36.
90. Mohiaddin RH, Pennell DJ. MR blood flow measurement. Clinical application in the heart and circulation. Cardiol Clin 1998;16:161.
91. Hartnell GG, Meier RA. MR angiography of congenital heart disease in adults. Radiographics 1995;15:781.
92. Fogel MA. Assessment of cardiac function by magnetic resonance imaging. Pediatr Cardiol 2000; 21(1):59-69.
93. Klein SS, Graham TPJ, Lorenz CH. Noninvasive delineation of normal right ventricular contractile motion with magnetic resonance imaging myocardial tagging. Ann Biomed Eng 1998;26:756.
94. Hubbard AM, States LJ. Fetal magnetic resonance imaging. Top Magn Reson Imaging 2001;12(2):93-103.